These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8565216)

  • 1. Chemiluminescent hybridization-ligation assays for delta F508 and delta I507 cystic fibrosis mutations.
    Martinelli RA; Arruda JC; Dwivedi P
    Clin Chem; 1996 Jan; 42(1):14-8. PubMed ID: 8565216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybridization of glass-tethered oligonucleotide probes to target strands preannealed with labeled auxiliary oligonucleotides.
    Maldonado-Rodriguez R; Espinosa-Lara M; Calixto-Suárez A; Beattie WG; Beattie KL
    Mol Biotechnol; 1999 Feb; 11(1):1-12. PubMed ID: 10367278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A deletion mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) locus: Delta I507.
    Schwarz M; Summers C; Heptinstall L; Newton C; Markham A; Super M
    Adv Exp Med Biol; 1991; 290():393-8. PubMed ID: 1719770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mismatch cleavage detects base deletion in cystic fibrosis gene.
    Hsu IC; Highsmith WE; Xu J; Kong D
    Biotechniques; 1998 Oct; 25(4):692-6. PubMed ID: 9793654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the I507 deletion by site-directed mutagenesis.
    Orozco L; Friedman K; Chávez M; Lezana JL; Villarreal MT; Carnevale A
    Am J Med Genet; 1994 Jun; 51(2):137-9. PubMed ID: 8092189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystic fibrosis with three mutations in the cystic fibrosis transmembrane conductance regulator gene.
    Dörk T; Wulbrand U; Richter T; Neumann T; Wolfes H; Wulf B; Maass G; Tümmler B
    Hum Genet; 1991 Aug; 87(4):441-6. PubMed ID: 1715308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-based oligonucleotide ligation assay for analysis of cystic fibrosis transmembrane conductance regulator gene mutations.
    Eggerding FA; Iovannisci DM; Brinson E; Grossman P; Winn-Deen ES
    Hum Mutat; 1995; 5(2):153-65. PubMed ID: 7538376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the cystic fibrosis gene in patients with disseminated bronchiectatic lung disease. Application in the identification of a cystic fibrosis patient with atypical clinical course.
    Poller W; Faber JP; Scholz S; Olek K; Müller KM
    Klin Wochenschr; 1991 Sep; 69(14):657-63. PubMed ID: 1749205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of mutation delta F508 in the cystic fibrosis gene using allele-specific PCR primers and time-resolved fluorometry.
    Iitiä A; Høgdall E; Dahlen P; Hurskainen P; Vuust J; Siitari H
    PCR Methods Appl; 1992 Nov; 2(2):157-62. PubMed ID: 1477671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segregation of delta F508 and normal CFTR alleles in human sperm.
    Williams C; Davies D; Williamson R
    Hum Mol Genet; 1993 Apr; 2(4):445-8. PubMed ID: 7684944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel natural product compound enhances cAMP-regulated chloride conductance of cells expressing CFTR[delta]F508.
    deCarvalho AC; Ndi CP; Tsopmo A; Tane P; Ayafor J; Connolly JD; Teem JL
    Mol Med; 2002 Feb; 8(2):75-87. PubMed ID: 12080183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of CFTR mutations in south-west German cystic fibrosis patients.
    Lindner M; Wolf A; Moh B; Steinbach P; Kleihauer E; Bartram CR; Kulozik AE
    Hum Genet; 1992 Nov; 90(3):267-9. PubMed ID: 1283148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic Fibrosis Mutation Detection with SPR Biosensor in Real Samples via Multiple Surfaces Binding Method.
    Kayran YU; Ozkan-Ariksoysal D; Topkaya SN; Kaymaz BT; Can BK
    Comb Chem High Throughput Screen; 2017; 20(1):56-63. PubMed ID: 28049404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal polymerase chain reaction amplification for preimplantation diagnosis in cystic fibrosis (delta F508).
    Cui KH; Haan EA; Wang LJ; Matthews CD
    BMJ; 1995 Aug; 311(7004):536-40. PubMed ID: 7545043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Frequency of delta F508 mutation in Venezuelan patients with cystic fibrosis].
    Morales-Machin A; Borjas-Fajardo L; Pineda L; González S; Delgado W; Zabala W; Fernández E
    Invest Clin; 2004 Jun; 45(2):121-30. PubMed ID: 15211979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis: frequency of delta f508 and g542x mutations in Cordoba, Argentina.
    Saleh MC; Botelli A; Melano de Botelli M; Rezzonico CA; Argaraña CE
    Medicina (B Aires); 1996; 56(1):14-6. PubMed ID: 8734924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mouse model for the delta F508 allele of cystic fibrosis.
    Zeiher BG; Eichwald E; Zabner J; Smith JJ; Puga AP; McCray PB; Capecchi MR; Welsh MJ; Thomas KR
    J Clin Invest; 1995 Oct; 96(4):2051-64. PubMed ID: 7560099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid cycle allele-specific amplification: studies with the cystic fibrosis delta F508 locus.
    Wittwer CT; Marshall BC; Reed GH; Cherry JL
    Clin Chem; 1993 May; 39(5):804-9. PubMed ID: 7683581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pooling strategy for heterozygote screening of the delta F508 cystic fibrosis mutation.
    Gille C; Grade K; Coutelle C
    Hum Genet; 1991 Jan; 86(3):289-91. PubMed ID: 1997384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do delta F508 heterozygotes have a selective advantage?
    Wiuf C
    Genet Res; 2001 Aug; 78(1):41-7. PubMed ID: 11556136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.